Lymph node staging in esophageal/junctional tumors after chemoradiotherapy: should we change strategy?

Endoscopy 2020; 52(04): 316
DOI: 10.1055/a-1103-1977

Letter to the editor

Gianenrico Rizzatti

¹Digestive Endoscopy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

²CERTT, Center for Endoscopic Research Therapeutics and Training, Catholic University, Rome, Italy

,

Mihai Rimbaș

³Gastroenterology and Internal Medicine Departments, Colentina Clinical Hospital, Carol Davila University of Medicine, Bucharest, Romania

,

Alberto Larghi

¹Digestive Endoscopy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

²CERTT, Center for Endoscopic Research Therapeutics and Training, Catholic University, Rome, Italy

References
1 van der Bogt RD, van der Wilk BJ, Poley JW. et al. Endoscopic ultrasound and fine-needle aspiration for the detection of residual nodal disease after neoadjuvant chemoradiotherapy for esophageal cancer. Endoscopy 2019;
2 Eyck BM, Onstenk BD, Noordman BJ. et al. Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer: A systematic review and meta-analysis. Ann Surg 2020; 271: 245-256
3 Vazquez-Sequeiros E, Wiersema MJ, Clain JE. et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 2003; 125: 1626-1635
4 Bang JY, Navaneethan U, Hasan MK. et al. Endoscopic ultrasound-guided specimen collection and evaluation techniques affect diagnostic accuracy. Clin Gastroenterol Hepatol 2018; 16: 1820-1828